Spain – Antineoplastic agents – Subsequent supply of the medicine "CILTACABTAGEN AUTOLEUCEL"
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Award of contract based on the Framework Agreement for the successive supply of the medicine "CILTACABTAGEN AUTOLEUCEL" for the Health Area of Coruña and Cee (Lot 2 of the Framework Agreement MA-SER1-25-038)